Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Li Di

Showing results (21-30 of 293) with videos related to

Pageof 30
Sort By:
World Journal of Gastrointestinal Surgery|December 30, 2024
Risk factors for lymph node metastasis and invasion depth in early gastric cancer: Analysis of 210 casesYu Xiang, Li-Di Yao
Drug Discovery Today|March 26, 2003
Pharmaceutical profiling in drug discoveryEdward H Kerns, Li Di
Drug Discovery Today|April 26, 2006
Biological assay challenges from compound solubility: strategies for bioassay optimizationLi Di, Edward H Kerns
Current Opinion in Drug Discovery & Development|July 19, 2005
Application of pharmaceutical profiling assays for optimization of drug-like propertiesLi Di, Edward H Kerns
Chirality|June 19, 2007
Rapid screening of enzymes for the enzymatic hydrolysis of chiral esters in drug discoveryChris Petucci, Li Di, Oliver McConnell
Expert Opinion on Drug Metabolism & Toxicology|June 1, 2021
Evolving approaches on measurements and applications of intracellular free drug concentration and Kp<sub>uu</sub> in drug discoveryLi Di, Keith Riccardi, David Tess
The AAPS Journal|December 5, 2022
Addressing the Accuracy of Plasma Protein Binding Measurement for Highly Bound Compounds Using the Dilution MethodSangwoo Ryu, David Tess, Li Di
Biopharmaceutics & Drug Disposition|November 2, 2019
Dasotraline as a selective cytochrome 2B6 inhibitor for reaction phenotypingXin Yang, Sangwoo Ryu, Li Di
Journal of Pharmaceutical Sciences|November 19, 2018
Evaluation of Cytochrome P450 Selectivity for Hydralazine as an Aldehyde Oxidase Inhibitor for Reaction PhenotypingXin Yang, Nathaniel Johnson, Li Di
Journal of Medicinal Chemistry|October 19, 2012
Demystifying brain penetration in central nervous system drug discovery. MiniperspectiveLi Di, Haojing Rong, Bo Feng
Pageof 30

Showing results (21-30 of 293) with videos related to

Sort By:
Pageof 30
World Journal of Gastrointestinal Surgery|December 30, 2024
Risk factors for lymph node metastasis and invasion depth in early gastric cancer: Analysis of 210 casesYu Xiang, Li-Di Yao
Drug Discovery Today|March 26, 2003
Pharmaceutical profiling in drug discoveryEdward H Kerns, Li Di
Drug Discovery Today|April 26, 2006
Biological assay challenges from compound solubility: strategies for bioassay optimizationLi Di, Edward H Kerns
Current Opinion in Drug Discovery & Development|July 19, 2005
Application of pharmaceutical profiling assays for optimization of drug-like propertiesLi Di, Edward H Kerns
Chirality|June 19, 2007
Rapid screening of enzymes for the enzymatic hydrolysis of chiral esters in drug discoveryChris Petucci, Li Di, Oliver McConnell
Expert Opinion on Drug Metabolism & Toxicology|June 1, 2021
Evolving approaches on measurements and applications of intracellular free drug concentration and Kp<sub>uu</sub> in drug discoveryLi Di, Keith Riccardi, David Tess
The AAPS Journal|December 5, 2022
Addressing the Accuracy of Plasma Protein Binding Measurement for Highly Bound Compounds Using the Dilution MethodSangwoo Ryu, David Tess, Li Di
Biopharmaceutics & Drug Disposition|November 2, 2019
Dasotraline as a selective cytochrome 2B6 inhibitor for reaction phenotypingXin Yang, Sangwoo Ryu, Li Di
Journal of Pharmaceutical Sciences|November 19, 2018
Evaluation of Cytochrome P450 Selectivity for Hydralazine as an Aldehyde Oxidase Inhibitor for Reaction PhenotypingXin Yang, Nathaniel Johnson, Li Di
Journal of Medicinal Chemistry|October 19, 2012
Demystifying brain penetration in central nervous system drug discovery. MiniperspectiveLi Di, Haojing Rong, Bo Feng
Pageof 30